Mechanisms and effectors of MIF-dependent promotion of tumourigenesis

被引:112
作者
Mitchell, RA [1 ]
机构
[1] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40202 USA
关键词
angiogenesis; cyclin D1; inflammation; MAP kinase; p53; transformation;
D O I
10.1016/j.cellsig.2003.07.002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The importance of secreted cytokines and growth factors in the development and promotion of malignancies is often underestimated. Many different soluble, extracellular gene products participate in processes that collectively contribute to the growth and survival of a developing neoplasm. These secreted molecules can, directly or indirectly, play a central role in uncontrolled tumour cell division, angiogenic stimulation or suppression of tumour cell immune surveillance. One of the first cytokine activities ever described, macrophage migration inhibitory factor (MIF), is unique to these soluble mediators in that it participates in all of these pro-tumourigenic processes. Overexpressed in most tumour types examined, MIF has been shown to promote malignant cell transformation, inhibit tumour cell-specific immune cytolytic responses and strongly enhance neovascularization. Despite this broad array of activities, the elucidation of molecular and cellular mechanisms involved in MIF-dependent bioactions has remained elusive. This review will focus on recently characterized phenotypes and mechanistic effectors thought to be associated with MIF-dependent promotion of neoplastic processes and discuss their relative importance in carcinogenesis. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:13 / 19
页数:7
相关论文
共 80 条
  • [1] Regulation of the CTL response by macrophage migration inhibitory factor
    Abe, R
    Peng, T
    Sailors, J
    Bucala, R
    Metz, CN
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (02) : 747 - 753
  • [2] Role of redox potential and reactive oxygen species in stress signaling
    Adler, V
    Yin, ZM
    Tew, KD
    Ronai, Z
    [J]. ONCOGENE, 1999, 18 (45) : 6104 - 6111
  • [3] An essential regulatory role for macrophage migration inhibitory factor in T-cell activation
    Bacher, M
    Metz, CN
    Calandra, T
    Mayer, K
    Chesney, J
    Lohoff, M
    Gemsa, D
    Donnelly, T
    Bucala, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) : 7849 - 7854
  • [4] Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme
    Bacher, M
    Schrader, J
    Thompson, N
    Kuschela, K
    Gemsa, D
    Waeber, G
    Schlegel, J
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (01) : 11 - 17
  • [5] Expression of macrophage migration inhibitory factor in human breast cancer: Association with nodal spread
    Bando, H
    Matsumoto, G
    Bando, M
    Muta, M
    Ogawa, T
    Funata, N
    Nishihira, J
    Koike, M
    Toi, M
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 2002, 93 (04): : 389 - 396
  • [6] ROS, stress-activated kinases and stress signaling in cancer
    Benhar, M
    Engelberg, D
    Levitzki, A
    [J]. EMBO REPORTS, 2002, 3 (05) : 420 - 425
  • [7] MIF IS A PITUITARY-DERIVED CYTOKINE THAT POTENTIATES LETHAL ENDOTOXEMIA
    BERNHAGEN, J
    CALANDRA, T
    MITCHELL, RA
    MARTIN, SB
    TRACEY, KJ
    VOELTER, W
    MANOGUE, KR
    CERAMI, A
    BUCALA, R
    [J]. NATURE, 1993, 365 (6448) : 756 - 759
  • [8] MECHANISM OF A REACTION IN VITRO ASSOCIATED WITH DELAYED-TYPE HYPERSENSITIVITY
    BLOOM, BR
    BENNETT, B
    [J]. SCIENCE, 1966, 153 (3731) : 80 - &
  • [9] Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis
    Bozza, M
    Satoskar, AR
    Lin, GS
    Lu, B
    Humbles, AA
    Gerard, C
    David, JR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (02) : 341 - 346
  • [10] Brekken RA, 2001, ANTICANCER RES, V21, P4221